
Charles River to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector Combines Cognate’s Comprehensive Cell...
Find Out More